Sep 12, 2022 / 03:40PM GMT
Vikram Purohit - Morgan Stanley, Research Division - Equity Analyst
Thanks, everyone, for joining. This is a fireside chat with Axsome Therapeutics. Let me read a brief disclosure statement before we get started. So for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. My name is Vikram Purohit. I'm one of the biotech analysts with the research team. Happy to have with me Herriot Tabuteau, CEO; and Mark Jacobson, COO of Axsome. Thanks for joining us.
Herriot Tabuteau - Axsome Therapeutics, Inc. - Founder, Chairman, CEO & President
Thank you.
Questions and Answers:
Vikram Purohit - Morgan Stanley, Research Division - Equity AnalystSo before we get into any specifics around pipeline Auvelity et cetera. Herriot, do you want to just level set for the audience and just provide a recap of some of the key milestones Axsome through work to do --